A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity

Nature Neuroscience

Volumn 18, Issue 3, 2015, Pages 379-387

  Verma, Pushpa ^a,b   Augustine, George J ^a,c,d,e   Ammar, Mohamed Raafet ^f,g   Tashiro, Ayumu ^f,g   Cohen, Stephen M ^a,b,h  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d Korea Institute of Science and Technology   (South Korea)

^e NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^f NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^g UNIVERSITY OF WARWICK   (United Kingdom)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; MICRORNA; MICRORNA 1000; MICRORNA 137; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER; VESICULAR GLUTAMATE TRANSPORTER 2; DROSOPHILA PROTEIN; MIRN100 MICRORNA, DROSOPHILA; MIRN100 MICRORNA, MOUSE; SLC17A6 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; EMBRYO; EXCITOTOXICITY; FEMALE; GENE; GENE DELETION; MALE; MIR 1000 GENE; NERVE CONDUCTION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; AGE; AGING; ANIMAL; ANIMAL EMBRYO; C57BL MOUSE; CELL CULTURE; DROSOPHILA; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE; NEURODEGENERATIVE DISEASES; TRANSGENIC ANIMAL;

AGE FACTORS; AGING; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELLS, CULTURED; DROSOPHILA; DROSOPHILA PROTEINS; EMBRYO, MAMMALIAN; EMBRYO, NONMAMMALIAN; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; NEURODEGENERATIVE DISEASES; SYNAPTIC TRANSMISSION; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 84923763986     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3935     Document Type: Article

References (42)

1. Hébert, S.S. et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression. Proc. Natl. Acad. Sci. USA 105, 6415-6420 (2008).
2. Delay, C., Mandemakers, W. & Hebert, S.S. MicroRNAs in Alzheimer's disease. Neurobiol. Dis. 46, 285-290 (2012).
3. Mouradian, M.M. MicroRNAs in Parkinson's disease. Neurobiol. Dis. 46, 279-284 (2012).
4. Gascon, E. & Gao, F.B. Cause or effect: misregulation of microRNA pathways in neurodegeneration. Front. Neurosci. 6, 48 (2012).
5. Haramati, S. et al. miRNA malfunction causes spinal motor neuron disease. Proc. Natl. Acad. Sci. USA 107, 13111-13116 (2010).
6. Gehrke, S., Imai, Y., Sokol, N. & Lu, B. Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466, 637-641 (2010).
7. Kim, J. et al. A microRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224 (2007).
8. Karres, J.S., Hilgers, V., Carrera, I., Treisman, J. & Cohen, S.M. The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 131, 136-145 (2007).
9. Liu, N. et al. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482, 519-523 (2012).
10. Kosik, K.S. The neuronal microRNA system. Nat. Rev. Neurosci. 7, 911-920 (2006).
11. McNeill, E. & Van Vactor, D. MicroRNAs Shape the Neuronal Landscape. Neuron 75, 363-379 (2012).
12. Schratt, G.M. et al. A brain-specific microRNA regulates dendritic spine development. Nature 439, 283-289 (2006).
13. Saba, R. et al. Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons. Mol. Cell. Biol. 32, 619-632 (2012).
14. Harraz, M.M., Eacker, S.M., Wang, X., Dawson, T.M. & Dawson, V.L. MicroRNA-223 is neuroprotective by targeting glutamate receptors. Proc. Natl. Acad. Sci. USA 109, 18962-18967 (2012).
15. Hu, Z. et al. Neurexin and neuroligin mediate retrograde synaptic inhibition in C. elegans. Science 337, 980-984 (2012).
16. Cohen, J.E., Lee, P.R., Chen, S., Li, W. & Fields, R.D. MicroRNA regulation of homeostatic synaptic plasticity. Proc. Natl. Acad. Sci. USA 108, 11650-11655 (2011).
17. Kim, D.S. et al. Bilateral enhancement of excitation via up-regulation of vesicular glutamate transporter subtype 1, not subtype 2, immunoreactivity in the unilateral hypoxic epilepsy model. Brain. Res. 1055, 122-130 (2005).
18. Touret, M., Parrot, S., Denoroy, L., Belin, M.F. & Didier-Bazes, M. Glutamatergic alterations in the cortex of genetic absence epilepsy rats. BMC Neurosci. 8, 69 (2007).
19. Helton, T.D., Otsuka, T., Lee, M.C., Mu, Y. & Ehlers, M.D. Pruning and loss of excitatory synapses by the parkin ubiquitin ligase. Proc. Natl. Acad. Sci. USA 105, 19492-19497 (2008).
20. Blandini, F. An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease. Funct. Neurol. 25, 65-71 (2010).
21. Raudensky, J. & Yamamoto, B.K. Effects of chronic unpredictable stress and methamphetamine on hippocampal glutamate function. Brain Res. 1135, 129-135 (2007).
22. Weng, R., Chen, Y.W., Bushati, N., Cliffe, A. & Cohen, S.M. Recombinase-mediated cassette exchange provides a versatile platform for gene targeting: knockout of miR-31b. Genetics 183, 399-402 (2009).
23. Bilen, J. & Bonini, N.M. Drosophila as a model for human neurodegenerative disease. Annu. Rev. Genet. 39, 153-171 (2005).
24. Kretzschmar, D., Hasan, G., Sharma, S., Heisenberg, M. & Benzer, S. The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J. Neurosci. 17, 7425-7432 (1997).
25. Daniels, R.W., Gelfand, M.V., Collins, C.A. & DiAntonio, A. Visualizing glutamatergic cell bodies and synapses in Drosophila larval and adult CNS. J. Comp. Neurol. 508, 131-152 (2008).
26. Reisberg, B. et al. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med. 348, 1333-1341 (2003).
27. Rothman, S.M. & Olney, J.W. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 18, 57-58 (1995).
28. Ibáñez-Ventoso, C., Vora, M. & Driscoll, M. Sequence relationships among C. elegans, D. melanogaster and human microRNAs highlight the extensive conservation of microRNAs in biology. PLoS ONE 3, e2818 (2008).
29. Liguz-Lecznar, M. & Skangiel-Kramska, J. Vesicular glutamate transporters (VGLUTs): the three musketeers of glutamatergic system. Acta Neurobiol. Exp. (Warsz.) 67, 207-218 (2007).
30. Boulland, J.L. et al. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J. Comp. Neurol. 480, 264-280 (2004).
31. Takamori, S. VGLUTs: 'exciting' times for glutamatergic research? Neurosci. Res. 55, 343-351 (2006).
32. Smrt, R.D. et al. MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 28, 1060-1070 (2010).
33. Daniels, R.W., Miller, B.R. & DiAntonio, A. Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration. Neurobiol. Dis. 41, 415-420 (2011).
34. Mark, K.A., Quinton, M.S., Russek, S.J. & Yamamoto, B.K. Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamineinduced glutamate release. J. Neurosci. 27, 6823-6831 (2007).
35. Tordera, R.M., Pei, Q. & Sharp, T. Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment. J. Neurochem. 94, 875-883 (2005).
36. Willemsen, M.H. et al. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability. J. Med. Genet. 48, 810-818 (2011).
37. Geekiyanage, H. & Chan, C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloid β, novel targets in sporadic Alzheimer's disease. J. Neurosci. 31, 14820-14830 (2011).
38. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976 (2011).
39. Kwon, E., Wang, W. & Tsai, L.H. Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol. Psychiatry 18, 11-12 (2013).
40. Gong, W.J. & Golic, K.G. Ends-out, or replacement, gene targeting in Drosophila. Proc. Natl. Acad. Sci. USA 100, 2556-2561 (2003).
41. Chen, Y.W., Weng, R. & Cohen, S.M. Protocols for use of homologous recombination gene targeting to produce microRNA mutants in Drosophila. Methods Mol. Biol. 732, 99-120 (2011).
42. Brennecke, J., Hipfner, D.R., Stark, A., Russell, R.B. & Cohen, S.M. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the pro-apoptotic gene hid in Drosophila. Cell 113, 25-36 (2003).